A #JACCCardioOnc perspective from Dr. @vijayrao7474.bsky.social, et al outlines the current state of #CardioOnc quality assessment and proposes a roadmap for meaningful metrics to improve care.

Get the details: bit.ly/3YhYnll #ACCCardioOnc @icosociety.bsky.social

Association of Malignancy With Stroke & Bleeding in #AFib: A Population-Based Cohort Study

#CardioSky #JACCCardioOnc #CardioOnc #Epeeps
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @avirupguha.bsky.social @gbarnesmd.bsky.social @ktamirisamd.bsky.social @vietheartpa.bsky.social

In AL cardiac #amyloidosis, combined 68Ga-FAPI-04 PET/CT & 18F-Florbetapir #cvNuc may have a complementary role for clinical decision-making

#CardioSky #JACCIMG
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @chriskramermd.bsky.social @mayocliniccancer.bsky.social @vietheartpa.bsky.social

Dr. Isabelle Mahe on the extended anticoagulant treatment with a reduced versus full dose #apixaban in patients with cancer-associated #VTE

#ACC25 #JACCJournals #APICAT #CardioOnc #cvCoag #CardioSky

In pts with active cancer who have completed at least 6 months of anticoagulant Tx:
🔹Extended anticoagulant therapy with reduced-dose #apixaban was non-inferior to full-dose apixaban to prevent recurrent VTE
🔹Reduced dose resulted in a lower incidence of clinically relevant bleeding

#ACC25

Hello #Medsky #CardioSky

The ESC is now on Bluesky🙂

We aim to bring you here the latest in cutting-edge cardiovascular science, from all ESC resources, including the successful #ESCTVToday CV news programme. We equally aim to bring you updates from all ESC communities and to bring you altogether.

Delighted to interview the co-chair of the ESC cardio-oncology guidelines #DrAlexLyon about his career in #CardioOnc #cardiology #oncology #cancer
Podcast Episode: JACC: CardioOncology Pulse - Cardio-Oncology Past, Present, and Future
gbr01.safelinks.protection.outlook.com?url=https%3A...

#AI to Enhance Precision Medicine in #CardioOnc:
Scientific Statement From American Heart Association

#CardioSky
www.ahajournals.org/doi/10.1161/...
@ahajournals.bsky.social @ahascience.bsky.social @avirupguha.bsky.social @joshmitchellmd.bsky.social @dramitkhera.bsky.social @rohankhera.bsky.social

In a contemporary population of patients w/ transthyretin amyloid cardiomyopathy (ATTR-CM) treated with tafamidis, long-term mortality was relatively high, according to a multicenter study published in #JACCCardioOnc.

More: bit.ly/4b2jm0J

#CardioOnc #MedSky #CardioSky @jaccjournals.bsky.social

Cardiovascular Considerations During Cancer Therapy: Gaps in Evidence & JACC: #CardioOncology Expert Panel Recommendations

#CardioSky #JACCCardioOnc
@jaccjournals.bsky.social @accintouch.bsky.social @avirupguha.bsky.social
www.jacc.org/doi/10.1016/...

No long-term adverse effect of surgical menopause (Salpingo-Oophorectomy) on development of #CAC

#CardioObstetrics #CardioSky #JACCCardioOnc
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @erinmichos.bsky.social @modeldoc.bsky.social @anastasiasmihaili.bsky.social @psatishmd.bsky.social

Stay connected & share your insights with the JACC Journals community by using our hashtags & tagging @jaccjournals.bsky.social:
📖 #JACC
🌟 #JACCAdvances
🌏 #JACCAsia
🔬 #JACCBTS
💙 #JACCCardioOnc
🩺 #JACCCaseReports
⚡️ #JACCCEP
❤️ #JACCHF
🩻 #JACCIMG
🚀 #JACCINT
📚 #JACCJournals
🎧 #JACCPodcast
💡 #JACCEdge

Premenopausal women with breast cancer treated with aromatase inhibitors & ovarian suppression may be at elevated CVD risk

#CardioSky #CardioOnc #JACCCardioOnc
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @avirupguha.bsky.social @anastasiasmihaili.bsky.social @psatishmd.bsky.social

Atherosclerotic CVD Are Associated With Incident Metastatic & Nonmetastatic Cancer

#CardioSky #MedSky #CardioOnc #JACCCardioOnc
www.jacc.org/doi/10.1016/...
@jaccjournals.bsky.social @avirupguha.bsky.social @vietheartpa.bsky.social @csilvers.bsky.social @anastasiasmihaili.bsky.social

Preventing, detecting, & managing CTR-CVT during cancer treatment is vital. A 3-part #JACCCardioOnc Expert Panel series reviews current evidence on CV care before, during, & after cardiotoxic cancer therapy, highlighting 🔑 evidence gaps acc.org/Latest-in-Ca... #CardiologyMag #CardioOnc #CardioSky

Encantados de recibir a nuestro amigo @pedromoliner.bsky.social para charlar sobre actualidad en CardioOncología en 2024. Excelente charla y trayectoria en este ámbito

📺¿Ya has descubierto todo lo que te ofrece #CanalSEC?

Revive los congresos y reuniones en cualquier momento, desde cualquier lugar y dispositivo. La plataforma se adapta a tus intereses, ofreciéndote una experiencia personalizada.

✨Acceso exclusivo para socios SEC: canalsec.es

Hi #CardioSky friends! 🌟 Tag us in your posts and let's work together to transform cardiovascular care and improve heart health for all 💖. Be sure to check out our journals too – give them a follow at @jaccjournals.bsky.social. 🦋